FC
AZN icon

Financial Consulate’s AstraZeneca AZN Stock Holding History

Financial Consulate’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$172K Buy
873
+62
+8% +$12K 0.02% 162
2025
Q4 		$149K Buy
811
+8
+1% +$1.4K 0.02% 194
2025
Q3 		$123K Buy
+803
New +$122K 0.02% 208

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Financial Consulate's AZN Position: Q1 2026 in Review

Financial Consulate increased its AstraZeneca (AZN) stake by 7.6% in Q1 2026, buying an estimated $12K and bringing the position to 873 shares worth $172K. The position accounts for 0.02% of the portfolio, ranked #162.

Financial Consulate first reported a position in AZN in Q3 2025 and has held it in 3 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Financial Consulate held 873 shares of AstraZeneca worth $172K as of Q1 2026.
  • Financial Consulate bought 62 AstraZeneca shares in Q1 2026, an estimated $12K.
  • AstraZeneca made up 0.02% of Financial Consulate's portfolio in Q1 2026, its #162 holding.
  • Financial Consulate first reported a position in AstraZeneca in Q3 2025 and has held it in 3 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.